Many individuals have been on a quest for the ideal weight loss solution, experimenting with various methods and medications over the years. Lately, a new approach has been gaining popularity: individuals incorporating the diabetes medication Ozempic into their weight loss journey.
However, it’s important to delve into the scientific findings surrounding this usage and understand what health professionals have to say about Ozempic as a tool for weight loss. Let’s take a closer look at the expert opinions on this topic.
Ozempic, whose generic name is semaglutide, received the green light from the U.S. Food and Drug Administration (FDA) in 2017 for treating adults with type 2 diabetes. This medication takes the form of a once-weekly injection that supports blood sugar management by enhancing insulin production in the pancreas. While it’s not officially endorsed for weight loss, some doctors do prescribe it for that purpose.
Ozempic operates by copying a hormone found naturally in your body. When this hormone increases, it sends signals to your brain, indicating that you’re full. Additionally, it decelerates digestion, prolonging the time food remains in your body. This process is akin to what happens after bariatric surgery. When Ozempic is used for diabetes treatment, weight loss often occurs as a typical side effect. It’s formulated for long-term use.
Research indicates that the active ingredient in Ozempic, semaglutide, can contribute to weight loss. However, it’s essential to maintain lifestyle changes like a healthy diet and regular exercise for effective weight management.
Although Ozempic itself is not officially approved for weight loss, semaglutide is available for weight loss purposes under the name Wegovy. It’s worth mentioning that Ozempic contains a smaller dose of semaglutide compared to Wegovy.
It’s crucial to be aware that when you start using these drugs for weight loss, your body may adjust, potentially leading to a weight plateau. Research suggests that discontinuing Ozempic (or Wegovy) could result in regaining the weight you had lost.
Wegovy is a once-a-week injection approved by the FDA in 2021 for long-term weight management, making it the first drug to receive such approval since 2014.
Both Ozempic and Wegovy are produced by the same company and share the same active ingredient, semaglutide. However, Wegovy contains higher semaglutide doses and is intended for weight loss, whereas Ozempic, with lower semaglutide doses, was primarily developed for individuals with type 2 diabetes.
Additionally, it’s worth noting that Ozempic is typically covered by health insurance, whereas Wegovy is often not covered.
Using Ozempic can support weight loss, which, in turn, may lower the risk of various health issues, like heart problems. In some cases, semaglutide treatments can serve as an alternative to bariatric surgery for people dealing with obesity. It’s essential to understand that surgical weight loss typically results in more substantial and longer-lasting weight reduction compared to medications.
However, experts advise against using Ozempic for weight loss unless you have type 2 diabetes. If you’re considering weight loss options, it’s best to consult your healthcare provider about starting Wegovy.
The FDA warns against the use of unapproved “generic” Ozempic and Wegovy, emphasising that there are no officially approved generic versions of these medications.
Despite this, there have been instances of unofficial versions of the drug appearing in compounding pharmacies throughout the United States. The FDA has received reports of adverse events in patients who used these “generic” semaglutide versions, which is the active ingredient found in both Ozempic and Wegovy.
Moreover, as of July 2023, there have been reports of a shortage of Ozempic and Wegovy. When individuals use Ozempic off-label for weight loss, it may lead to difficulties for type 2 diabetes patients who rely on Ozempic to access their necessary medication.
Follow us on Google News